Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Aparapotamon grahami

ABSTRACT: Aparapotamon grahami Genome sequencing and assembly

PROVIDER: PRJNA768259 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16181045_1.fastq.gz	Fastqsanger.gz
	SRR16181045_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Oreochromis grahami isolate:041103

Project description:Oreochromis grahami isolate:041103 Genome sequencing and assembly

| PRJNA932931 | ENA

Oreochromis grahami

Project description:Oreochromis grahami overview

| PRJNA933338 | ENA

Sinocyclocheilus grahami

Project description:Sinocyclocheilus grahami overview

| PRJNA274152 | ENA

Anabarilius grahami

Project description:Anabarilius grahami overview

| PRJNA660518 | ENA

Sinocyclocheilus grahami

Project description:Sinocyclocheilus grahami Raw sequence reads

| PRJNA907410 | ENA

Anabarilius grahami isolate:AG-KIZ

Project description:Anabarilius grahami isolate:AG-KIZ Genome sequencing and assembly

| PRJNA477399 | ENA

Sinocyclocheilus grahami isolate:CB-2024B

Project description:Sinocyclocheilus grahami isolate:CB-2024B Genome sequencing

| PRJNA1172646 | ENA

Anabarilius grahami breed:Kanglang white minnow

Project description:The transcriptome sequencing of liver of Anabarilius grahami

| PRJNA594805 | ENA

Project description:Sinocyclocheilus grahami genome

| PRJNA702560 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data